Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Evista (raloxifene hydrochloride) Tablets, 60 mg.
Company: Eli Lilly and Company
NDA: 022042
Approval Date: 9/13/2007

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

  • Administrative Document(s) and Correspondence (PDF)


Date created: March 12, 2009

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.